thrombopoietin receptor; TPO-R; myeloproliferative leukemia protein; C-mpl; CD110 (MPL, TPOR)
Jump to navigation
Jump to search
Function
- receptor for thrombopoietin
- induces megakaryocyte proliferation & differentiation
- prevents apoptosis
- may represent a regulatory molecule specific for TPO-R-dependent immune responses
- interacts with ATXN2L
Structure
- WSXWS motif appears to be necessary for proper protein folding & thus efficient intracellular transport & cell-surface receptor binding
- box 1 motif is required for JAK interaction &/or activation
- belongs to the type I cytokine receptor family, type 1 subfamily
- contains 2 fibronectin F3 modules
Compartment
membrane
Alternative splicing
named isoforms=2
Expression
- megakaryocytes & progenitors
- platelets
- expressed at a low level in a large number of cells of hematopoietic origin
- isoform 1 & isoform 2 are always coexpressed
Pathology
- defects in MPL are a cause of
Pharmacology
- avatrombopag (Doptelet) is a thrombopoietin receptor agonist that stimulates platelet production[4]
Laboratory
Notes
uncertain whether Met-1 or Met-8 is the initiator
More general terms
Additional terms
References
- ↑ UniProt http://www.uniprot.org/uniprot/P40238.html
- ↑ GeneReviews https://www.genecards.org/cgi-bin/carddisp.pl?gene=MPL
- ↑ http://www.pathologyoutlines.com/cdmarkers.html 21 June 2005
- ↑ 4.0 4.1 Brooks M FDA OKs Platelet Booster for Liver Disease Patients . Medscape - May 21, 2018 https://www.medscape.com/viewarticle/897029